Publication | Open Access

2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors

Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug DesignPharmacological AgentNew ClassPharmacotherapyDrug DevelopmentChemical BiologyPharmacologyMolecular ModelingPharmaceutical ChemistryDrug DiscoveryGlycosylation